Daebongls.Co.Ltd - Asset Resilience Ratio
Daebongls.Co.Ltd (078140) has an Asset Resilience Ratio of 17.35% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Daebongls.Co.Ltd total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2024)
This chart shows how Daebongls.Co.Ltd's Asset Resilience Ratio has changed over time. See 078140 total equity for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Daebongls.Co.Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Daebongls.Co.Ltd worth.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩44.31 Billion | 17.35% |
| Total Liquid Assets | ₩44.31 Billion | 17.35% |
Asset Resilience Insights
- Good Liquidity Position: Daebongls.Co.Ltd maintains a healthy 17.35% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
Daebongls.Co.Ltd Industry Peers by Asset Resilience Ratio
Compare Daebongls.Co.Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Sam-A Pharm. Co. Ltd
KQ:009300 |
Pharmaceuticals | 36.86% |
|
GeneBioTech Co. Ltd
KQ:086060 |
Pharmaceuticals | 15.42% |
|
Sam Chun Dang Pharm. Co. Ltd
KQ:000250 |
Pharmaceuticals | 4.82% |
|
ST Pharm Co.Ltd
KQ:237690 |
Pharmaceuticals | 7.72% |
|
Oscotec Inc
KQ:039200 |
Pharmaceuticals | 61.00% |
|
Caregen Co.Ltd
KQ:214370 |
Pharmaceuticals | 4.58% |
|
NatureCell Co.Ltd
KQ:007390 |
Pharmaceuticals | 0.00% |
|
Mezzion Pharma Co.Ltd
KQ:140410 |
Pharmaceuticals | 13.09% |
Annual Asset Resilience Ratio for Daebongls.Co.Ltd (2011–2024)
The table below shows the annual Asset Resilience Ratio data for Daebongls.Co.Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-12-31 | 31.74% | ₩75.76 Billion ≈ $51.34 Million |
₩238.71 Billion ≈ $161.77 Million |
-5.34pp |
| 2023-12-31 | 37.08% | ₩72.27 Billion ≈ $48.98 Million |
₩194.92 Billion ≈ $132.09 Million |
-11.38pp |
| 2022-12-31 | 48.46% | ₩90.20 Billion ≈ $61.13 Million |
₩186.14 Billion ≈ $126.14 Million |
+9.91pp |
| 2021-12-31 | 38.54% | ₩62.92 Billion ≈ $42.64 Million |
₩163.24 Billion ≈ $110.62 Million |
-8.81pp |
| 2020-12-31 | 47.35% | ₩70.93 Billion ≈ $48.07 Million |
₩149.79 Billion ≈ $101.51 Million |
+27.34pp |
| 2019-12-31 | 20.02% | ₩20.44 Billion ≈ $13.85 Million |
₩102.13 Billion ≈ $69.21 Million |
-0.07pp |
| 2018-12-31 | 20.09% | ₩17.46 Billion ≈ $11.83 Million |
₩86.93 Billion ≈ $58.91 Million |
+1.38pp |
| 2017-12-31 | 18.71% | ₩15.05 Billion ≈ $10.20 Million |
₩80.45 Billion ≈ $54.52 Million |
+0.44pp |
| 2016-12-31 | 18.27% | ₩13.78 Billion ≈ $9.34 Million |
₩75.43 Billion ≈ $51.12 Million |
+2.68pp |
| 2015-12-31 | 15.58% | ₩10.20 Billion ≈ $6.91 Million |
₩65.47 Billion ≈ $44.37 Million |
+3.75pp |
| 2014-12-31 | 11.83% | ₩6.70 Billion ≈ $4.54 Million |
₩56.65 Billion ≈ $38.39 Million |
+1.19pp |
| 2013-12-31 | 10.64% | ₩5.43 Billion ≈ $3.68 Million |
₩51.03 Billion ≈ $34.58 Million |
+3.42pp |
| 2012-12-31 | 7.22% | ₩3.36 Billion ≈ $2.28 Million |
₩46.55 Billion ≈ $31.54 Million |
-6.40pp |
| 2011-12-31 | 13.63% | ₩5.97 Billion ≈ $4.05 Million |
₩43.84 Billion ≈ $29.71 Million |
-- |
About Daebongls.Co.Ltd
Daebongls.Co.,Ltd. engages in the research, development, and production of cosmetics, pharmaceutical raw materials, food and feed products in South Korea and internationally. The company's Cosmetic Ingredients division offers special cosmetic ingredients comprising fresh green tea, black ginseng water, jeju hatban extract, wormwood extract, jeju camellia oil, jeju dang oil extract, jeju basalt po… Read more